Navigation Links
MicuRx Completes $25 Million Series B Financing
Date:8/22/2013

ical trials in China, through the joint venture Shanghai MengKe Pharmaceuticals with Shanghai Zhangjiang Biomedical Industry Venture Capital, we look forward to initiating development of MRX-I through a Phase 2 clinical trial at selected centers in the United States, to ensure successful development of this compound internationally. Importantly, BVCF will be an exceptional partner for MicuRx, with broad contacts internationally and extensive healthcare experience to guide our strategic development and commercialization plans."

MRX-I: A Potent and Safe Oxazolidinone Antibiotic
MRX-I is a next-generation oral oxazolidinone antibiotic for treating Gram-positive bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Phase I clinical results demonstrated that MRX-I is safe and well tolerated in human subjects, with no signs of myelosuppression, the major toxicity concern for most oxazolidinone agents, including linezolid. In preclinical studies, MRX-I cures in vivo infections due to Gram-positive bacteria including MRSA and VRE effectively. In addition, MRX-I exhibits two-fold improved activity against MRSA strains as compared to linezolid.

About BVCF
BVCF (http://bvcf.com/, formally known as BioVeda China) is the first and go-to private equity and growth capital investor specializing in China Life Sciences and Healthcare industry. Headquartered in Shanghai, BVCF's team includes partners with premier academic background and extensive operational experience. Investors include institutional limited partners and leading MNC pharmaceutical companies. BVCF focuses on investment in mid-market (US$ 50 – 100 million enterprise value) Life Science and Healthcare companies in China. The BVCF team takes an active app
'/>"/>

SOURCE MicuRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MicuRx Pharmaceuticals Announces Issuance Of U.S. Patent For Its Next-Generation Antibacterial Agent
2. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
3. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
4. NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels
5. CryoLife Completes Acquisition of Hemosphere
6. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
7. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
8. Jazz Pharmaceuticals Completes EUSA Pharma Acquisition
9. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
10. Ablative Solutions Completes $5.3M Series A Financing
11. Quantum OPS Completes $1.05M In Series A Financing To Advance Surgical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... YORK , Sept. 29, 2014 EU5 ... Summary GlobalData,s new report, "EU5 Capsule ... data on the EU5 Capsule Endoscopy Systems market. The ... (in units) and average prices (in US dollars) within ... and Capsule Endoscopy Workstations. The report also ...
(Date:9/29/2014)... Pharmaceutical Care Management Association (PCMA) President and ... that could reduce prescription fraud and abuse in Medicare ... Opioid Abuse: Fighting Back on Many Fronts ," sponsored ... The briefing featured several government and industry ... fraud. The Centers for Disease Control and Prevention has ...
(Date:9/29/2014)... LAKE CITY , Sept. 29, 2014 /PRNewswire/ ... has scheduled a conference call for investors today ... for the quarter and year ended June 30, ... in participating is (800) 771-7941. Dynatronics ... soft goods and supplies, treatment tables and rehabilitation ...
Breaking Medicine Technology:EU5 Capsule Endoscopy Systems Market Outlook to 2020 2EU5 Capsule Endoscopy Systems Market Outlook to 2020 3PCMA: How Congress Can Fight Prescription Drug Fraud and Abuse 2
... 2011 Genomic Health, Inc. (Nasdaq: GHDX ) today ... on Wednesday, August 3 at 4:30 p.m. Eastern Time to discuss ... follow the release of the second quarter financial results after market ... To access the live conference call on August 3 at ...
... July 27, 2011 For men facing radical prostatectomy ... not their only concern. In fact, a large number of ... continence among their biggest fears. More than 240,000 men will ... patients of Dr. David Samadi,s, Vice Chairman, Department of Urology, ...
Cached Medicine Technology:Genomic Health to Announce Second Quarter 2011 Financial Results and Host Conference Call on Wednesday, August 3, 2011 2Genomic Health to Announce Second Quarter 2011 Financial Results and Host Conference Call on Wednesday, August 3, 2011 3Post Robotic Prostate Surgery Continence and Pelvic Floor Muscles 2Post Robotic Prostate Surgery Continence and Pelvic Floor Muscles 3
(Date:9/30/2014)... 2014 A highlight for this year’s ... the American Academy of Ophthalmology meeting in Chicago will ... Jeffrey Martin, MD on the latest advances in ... Partner of North Shore Eye Care and is an ... , This year’s 118th Annual American Academy of Ophthalmology ...
(Date:9/30/2014)... 2014 (HealthDay News) -- In books and movies, plots involving ... Now, new research suggests that the stereotype may be ... at data on more than 12,000 people from Finland. ... Turku, Finland, found that women typically preferred men who were ... throughout their lives. On the other hand, men tended ...
(Date:9/30/2014)... ARBORResearchers at the University of Michigan have described a ... a fraction of the time needed for more traditional ... a novel antibody that is undergoing further investigation as ... , In research published online in ... , researchers in the lab of Stephen Weiss at ...
(Date:9/30/2014)... MYERS, Fla. (PRWEB) September 30, 2014 ... Hospital, is giving breast cancer patients a new, more ... surgeries. , Women who undergo mastectomies, biopsies and lumpectomy ... and promote healing. But after seeing her patients describe ... felt compelled to create a new bra in her ...
(Date:9/30/2014)... Florida (PRWEB) September 30, 2014 Brig ... in history, who broke over 500 Diamond-ranked professionals using ... is doing it again. The Life Support System ... systems he has been perfecting using his experiences and ... this month. Using the principles and methodology taught by ...
Breaking Medicine News(10 mins):Health News:Global Laser Technology Leader Selects Jeffrey Martin, MD To Address Colleagues During International Symposium In Chicago 2014 2Health News:Global Laser Technology Leader Selects Jeffrey Martin, MD To Address Colleagues During International Symposium In Chicago 2014 3Health News:When It Comes to Sex Partners, Men Prefer Younger Women: Study 2Health News:New discovery approach accelerates identification of potential cancer treatments 2Health News:Surgeon Creates New Bra for Breast Cancer Patients, Post-Surgery 2Health News:Surgeon Creates New Bra for Breast Cancer Patients, Post-Surgery 3Health News:Brig Hart Announces the First Diamond Elite Representatives using his Life Support System 2Health News:Brig Hart Announces the First Diamond Elite Representatives using his Life Support System 3
... urged Australians to spare a thought this week for those ... of year for most people means joyful gatherings with friends ... despair,' Dr Yong said. ,'The social circuit, gift-giving ... cause depression for those who are socially isolated. ...
... of Alzheimer's disease (AD) according to a study conducted ... one// in a group of related steroid hormones referred ... in the December 20 issue of The Journal of ... loss and AD, which affects 4.5 million Americans. ...
... .But for about 10% to 20 % of women menopausal ... night sweats, hot// flashes (sensation of heat which comes on ... Replacement Therapy (HRT) is the conventional treatment of choice that ... menopausal period. Hormone therapy offers great relief from hot flashes ...
... Sharad Pawar was Tuesday admitted to a hospital here ... ,The Nationalist Congress Party (NCP) chief was on way ... in the evening when he complained of ill health. ... south Delhi. ,"He is under observation," said ...
... Anbumani Ramadoss Monday stressed the need for inter-state ... drugs.// ,"States should create a good system ... on the culprits. They should share the information ... menace," Ramadoss said., ,Inaugurating the 37th Drug ...
... a new anti-rabies vaccine Rabirix that can be used ... of infection due to animal bite or contact with ... been indigenously developed by BBIL and "can be used ... treatments", said Krishna M. Ella, chairman and managing director ...
Cached Medicine News:Health News:Increase Testosterone Levels To Slow Down Alzheimer’ 2Health News:Natural Remedies Ineffective to Ease Menopausal Symptoms:study 2Health News:Bharat Biotech Launches Anti-Rabies Vaccine 2
... EZLink was designed to provide optimal ... associated with a larger network system. Most ... - up to three workstations located in ... features and performance. For creating a paperless ...
A comprehensive and cost effective LIS solution for the Physicians Office Laboratory....
LabPak II is a comprehensive multi-user Laboratory Information System designed to meet the requirements of the larger POL, small hospital or private laboratory. It is the next step up from the LabPak...
... BMP™ Total Hip Pouch Drape is designed as an ... to dislocate the lower extremity into a sterile pouch ... clear poly and is a generous 60 inches long ... the extremity with a 4 inch wide adhesive strip ...
Medicine Products: